TheCorporateCounsel.net

Late last week, the SEC posted notice that it was extending the time period for action on Nasdaq’s proposal to accelerate the delisting process for non-compliance with minimum bid price requirements. I blogged about the proposed amendment when it was published in August – and Meredith shared follow-up commentary that AI and biotech startups are most at risk of delisting if the rule is approved.

The Commission has now designated November 21st as the date by which it will either approve or disapprove, or institute proceedings to determine whether to disapprove, the proposed rule change.

– Liz Dunshee